– Review of the Unyvero System and Lower Respiratory Tract (LRT) Cartridge is nearing completion – U.S. commercial team and operational infrastructure in place Amsterdam, the […]

Dec 19, 2017 NEW YORK (GenomeWeb) – Epigenomics announced today that it has received CE-IVD marking for its blood-based lung cancer test Epi proLung. Epi proLung […]

Curetis Publishes Business and Financial Update for the First Nine Months of 2017 – Preparing for expected U.S. FDA clearance decision on Unyvero System and Unyvero […]

Curetis initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge –      Initial patient samples collected for second U.S. Unyvero Product Study –      Prospective clinical trial expected to […]

MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics –        Broad collaboration to develop a targeted Next-Generation Sequencing assay for microbial infections –        Workflow for native samples […]

BERLIN, and GERMANTOWN, Md., Aug. 30, 2017 /PRNewswire/ — Epigenomics AG (Frankfurt Prime Standard: ECX) (OTCQX: EPGNY), today announced the initiation of a Post Approval Study […]

  – Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches with Biotest’s Pentaglobin® in peritonitis patients – Curetis to provide testing services for […]

Curetis Provides Update on Unyvero LRT FDA 510(k) Submission – Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the […]

Curetis Files for U.S. FDA Clearance for Unyvero Platform and LRT Application Cartridge – Final panel demonstrates overall weighted average sensitivity of 91.4% and overall weighted […]